Asymchem Laboratories Tianjin CoASLTY 69 Return-on-Tangible-Equity is 7.14% as of Mar. 2026, which is 60% below its 10-year median of 17.68. GuruFocus rates ASLTY with a GF Score™ of 69/100 and a GF Value™ of $3.90 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,200 Biotechnology companies, Asymchem Laboratories Tianjin Co ranks better than 83.58% on this metric.
The historical rank and industry rank for Asymchem Laboratories Tianjin Co's Return-on-Tangible-Equity or its related term are showing as below:
ASLTY'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 5.73 Med: 17.68 Max: 24.35
Current: 6.58
During the past 13 years, Asymchem Laboratories Tianjin Co's highest Return-on-Tangible-Equity was 24.35%. The lowest was 5.73%. And the median was 17.68%.
ASLTY's Return-on-Tangible-Equity is ranked better than 83.58% of 1200
companies
in the Biotechnology industry
Industry Median: -42.435
vs ASLTY: 6.58
Asymchem Laboratories Tianjin Co (OTCPK:ASLTY) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Asymchem Laboratories Tianjin Co Return-on-Tangible-Equity Related Terms
Asymchem Laboratories Tianjin Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asymchem Laboratories Tianjin Co Return-on-Tangible-Equity Chart
ASLTY vs VRTX, REGN, ALNY: Return-on-Tangible-Equity Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co Return-on-Tangible-Equity vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 7.14% mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a Return-on-Tangible-Equity of 7.14% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Asymchem Laboratories Tianjin Co and its competitors. This is 60% below median its historical median of 17.68. Over the past decade, Asymchem Laboratories Tianjin Co's Return-on-Tangible-Equity has ranged from 5.73 to 24.35. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #197 out of 1200 companies in the Biotechnology industry, placing it in the top 16.4%.
Is Asymchem Laboratories Tianjin Co's Return-on-Tangible-Equity too high?
Asymchem Laboratories Tianjin Co's current Return-on-Tangible-Equity of 7.14% is 60% below median its 10-year median of 17.68. Over the past 10 years, this metric has ranged from a low of 5.73 to a high of 24.35. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #197 out of 1200 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Return-on-Tangible-Equity compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #197 out of 1200 companies for Return-on-Tangible-Equity. This places Asymchem Laboratories Tianjin Co in the top 16% of its industry — outperforming the majority of peers. Historically, Asymchem Laboratories Tianjin Co's own Return-on-Tangible-Equity has ranged from 5.73 to 24.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Biotechnology company?
A good Return-on-Tangible-Equity depends on the Biotechnology industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Asymchem Laboratories Tianjin Co and its competitors. Asymchem Laboratories Tianjin Co's current Return-on-Tangible-Equity is 7.14%, which is 60% below median its own 10-year median of 17.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.90, compared to a current price of $6.37 — trading 63.3% above its estimated fair value. The current Return-on-Tangible-Equity is 7.14%, which is 60% below median its 10-year median of 17.68. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Return-on-Tangible-Equity is 7.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $6.37 is trading 63.3% above its estimated GF Value™ of $3.90.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
Return-on-Tangible-Equity: 7.14% (60% below median its 10-year median of 17.68)
GF Value™: $3.90 vs. price of $6.37 (63.3% above fair value)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Business Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score
Get the complete analysis for ASLTY
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 
